Cargando…

Altered Thyroid Function Tests Observed in Hypophosphatasia Patients Treated with Asfotase Alfa

BACKGROUND: Asfotase alfa is the only approved treatment that can normalize mineralization in patients with hypophosphatasia (HPP). Its interference in alkaline phosphatase (ALP) dependent immunoassays has been reported. OBJECTIVE: To describe thyroid function tests interfered with by asfotase alfa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kato, Hajime, Hidaka, Naoko, Koga, Minae, Kinoshita, Yuka, Nangaku, Masaomi, Makita, Noriko, Ito, Nobuaki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8568557/ https://www.ncbi.nlm.nih.gov/pubmed/34745256 http://dx.doi.org/10.1155/2021/5492267

Ejemplares similares

Radiological evaluation of pseudofracture after the administration of asfotase alfa in an adult with benign prenatal hypophosphatasia: A case report
por: Kato, Hajime, et al.
Publicado: (2021)

Pathophysiology of hypophosphatasia and the potential role of asfotase alfa
por: Orimo, Hideo
Publicado: (2016)

Induction of FGF23-related hypophosphatemic osteomalacia by alcohol consumption
por: Hidaka, Naoko, et al.
Publicado: (2021)

Pharmacokinetics of Asfotase Alfa in Adult Patients With Pediatric‐Onset Hypophosphatasia
por: Pan, Wei‐Jian, et al.
Publicado: (2021)

Excellent response to asfotase alfa treatment in an adolescent patient with hypophosphatasia
por: Strandbech, Olivia Sarah, et al.
Publicado: (2021)

A Rare Case of Perinatal Hypophosphatasia Treated With Asfotase Alfa
por: Srivastava, Priya S, et al.
Publicado: (2021)

Effect of Asfotase Alfa in the Treatment of Hypophosphatasia- A Systematic Review
por: Jaswanthi, N, et al.
Publicado: (2023)

Profile of asfotase alfa in the treatment of hypophosphatasia: design, development, and place in therapy
por: Bowden, Sasigarn A, et al.
Publicado: (2018)

Clinical performance of a new intact FGF23 immunoassay in healthy individuals and patients with chronic hypophosphatemia
por: Kato, Hajime, et al.
Publicado: (2023)

Incidence of ossification of the spinal ligaments in acromegaly patients
por: Hoshino, Yoshitomo, et al.
Publicado: (2022)

Successful Asfotase Alfa Treatment in an Adult Dialysis Patient With Childhood-Onset Hypophosphatasia
por: Remde, Hanna, et al.
Publicado: (2017)

Fracture Healing in Two Adult Patients With Hypophosphatasia After Asfotase Alfa Therapy
por: Klidaras, Philostratos, et al.
Publicado: (2018)

MON-497 Adult Onset Hypophosphatasia: Before and After Treatment with Asfotase Alfa
por: Magdaleno, Angela, et al.
Publicado: (2019)

Bone turnover and mineral metabolism in adult patients with hypophosphatasia treated with asfotase alfa
por: Seefried, L., et al.
Publicado: (2021)

THU460 A Case Series Of Hypophosphatasia: Presentation And Response To Asfotase Alfa
por: Alsarraf, Farah, et al.
Publicado: (2023)

Hearing impairment improved after treatment with asfotase alfa in a case of perinatal hypophosphatasia
por: Chida-Naomiya, Rie, et al.
Publicado: (2020)

OR13-4 Safety Profile of Asfotase Alfa Treatment of Patients with Hypophosphatasia: A Pooled Analysis
por: Whyte, Michael, et al.
Publicado: (2019)

A Japanese single-center experience of the efficacy and safety of asfotase alfa in pediatric-onset hypophosphatasia
por: Sugiyama, Yohei, et al.
Publicado: (2022)

Physical Function and Health‐Related Quality of Life in Adults Treated With Asfotase Alfa for Pediatric‐Onset Hypophosphatasia
por: Genest, Franca, et al.
Publicado: (2020)

Effect of Asfotase Alfa on Muscle Weakness in a Japanese Adult Patient of Hypophosphatasia with Low ALP Levels
por: Koyama, Hiroyuki, et al.
Publicado: (2019)

Machine Learning–Based Prediction of Elevated PTH Levels Among the US General Population
por: Kato, Hajime, et al.
Publicado: (2022)

Efficacy and Safety of Asfotase Alfa in Infants and Young Children With Hypophosphatasia: A Phase 2 Open-Label Study
por: Hofmann, Christine E, et al.
Publicado: (2019)

Utility of Multimodality Approach Including Systemic FGF23 Venous Sampling in Localizing Phosphaturic Mesenchymal Tumors
por: Kato, Hajime, et al.
Publicado: (2022)

Improvement of bone microarchitecture parameters after 12 months of treatment with asfotase alfa in adult patient with hypophosphatasia: Case report
por: Freitas, Thiago Quadrante, et al.
Publicado: (2018)

Asfotase alfa has a limited effect in improving the bowed limbs in perinatal benign hypophosphatasia: A case report
por: Matsushita, Masaki, et al.
Publicado: (2021)

A two-year follow-up of asfotase alfa replacement in a patient with hypophosphatasia: clinical, biochemical, and radiological evaluation
por: Reis, Fernanda Salles, et al.
Publicado: (2020)

Case Report: Efficacy of Reduced Doses of Asfotase Alfa Replacement Therapy in an Infant With Hypophosphatasia Who Lacked Severe Clinical Symptoms
por: Fujisawa, Yasuko, et al.
Publicado: (2020)

Odontohypophosphatasia treated with asfotase alfa enzyme replacement therapy in a toddler: a case report
por: Takagi, Mizuki, et al.
Publicado: (2020)

Marked motor function improvement in a 32-year-old woman with childhood-onset hypophosphatasia by asfotase alfa therapy: Evaluation based on standardized testing batteries used in Duchenne muscular dystrophy clinical trials
por: Nishizawa, Hitomi, et al.
Publicado: (2020)

Ectopic expression of Klotho in fibroblast growth factor 23 (FGF23)-producing tumors that cause tumor-induced rickets/osteomalacia (TIO)
por: Kinoshita, Yuka, et al.
Publicado: (2018)

Tumor-induced Osteomalacia Caused by a Parotid Tumor
por: Takashi, Yuichi, et al.
Publicado: (2017)

Hypophosphatasia
por: Mornet, Etienne
Publicado: (2007)

Hypophosphatasia
por: Tournis, Symeon, et al.
Publicado: (2021)

Activation of unliganded FGF receptor by extracellular phosphate potentiates proteolytic protection of FGF23 by its O-glycosylation
por: Takashi, Yuichi, et al.
Publicado: (2019)

Successful prednisolone or calcimimetic treatment of acquired hypocalciuric hypercalcemia caused by biased allosteric CaSR autoantibodies
por: Makita, Noriko, et al.
Publicado: (2022)

Alkaline Phosphatase and Hypophosphatasia
por: Millán, José Luis, et al.
Publicado: (2015)

Update on the management of hypophosphatasia
por: Choida, V., et al.
Publicado: (2019)

Transformative therapy in hypophosphatasia
por: Bishop, Nick, et al.
Publicado: (2016)

Hypophosphatasia: The Unusual Presentation
por: Sergi, Consolato M.
Publicado: (2020)

CFH-CFHR1 hybrid genes in two cases of atypical hemolytic uremic syndrome
por: Sugawara, Yuka, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_g9t2o7pi42lkt1d24hahbdeg29